151 related articles for article (PubMed ID: 10362136)
21. Abnormal transcripts of FHIT gene in thyroid cancer.
Chang TJ; Tsai TC; Wu YL; Yang HM; Chi CW; Yang AH; Lee CH
Oncol Rep; 1998; 5(1):245-7. PubMed ID: 9458330
[TBL] [Abstract][Full Text] [Related]
22. Aberrant transcripts of FHIT, TSG101 and PTEN/MMAC1 genes in normal peripheral mononuclear cells.
Wang NM; Chang JG; Liu TC; Lin SF; Peng CT; Tsai FJ; Tsai CH
Int J Oncol; 2000 Jan; 16(1):75-80. PubMed ID: 10601551
[TBL] [Abstract][Full Text] [Related]
23. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
24. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
25. fhit Alterations in endometrial carcinoma and hyperplasia.
Ozaki K; Enomoto T; Yoshino K; Hongbo S; Nakamura T; Fujita M; Kuragaki C; Sakata M; Kurachi H; Murata Y
Int J Cancer; 2000 Feb; 85(3):306-12. PubMed ID: 10652418
[TBL] [Abstract][Full Text] [Related]
26. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines].
Lee SH; Kim HS
Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704
[TBL] [Abstract][Full Text] [Related]
27. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
[TBL] [Abstract][Full Text] [Related]
28. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
29. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
[TBL] [Abstract][Full Text] [Related]
30. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
31. Study of FHIT transcripts in normal and malignant breast tissue.
Bièche I; Latil A; Becette V; Lidereau R
Genes Chromosomes Cancer; 1998 Dec; 23(4):292-9. PubMed ID: 9824201
[TBL] [Abstract][Full Text] [Related]
32. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
33. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.
Pichiorri F; Trapasso F; Palumbo T; Aqeilan RI; Drusco A; Blaser BW; Iliopoulos D; Caligiuri MA; Huebner K; Croce CM
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3494-501. PubMed ID: 16740775
[TBL] [Abstract][Full Text] [Related]
34. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.
Iwai M; Kiyoi H; Ozeki K; Kinoshita T; Emi N; Ohno R; Naoe T
Leukemia; 2005 Aug; 19(8):1367-75. PubMed ID: 15902282
[TBL] [Abstract][Full Text] [Related]
35. FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases.
Luan X; Ramesh KH; Cannizzaro LA
Cytogenet Cell Genet; 1998; 81(3-4):183-8. PubMed ID: 9730598
[TBL] [Abstract][Full Text] [Related]
36. Transcription of genes of p53-dependent apoptosis in acute leukaemia.
Racay P; Hatok J; Hudecek J; Chudej J; Jurecekova J; Dobrota D
Int J Mol Med; 2008 Dec; 22(6):833-9. PubMed ID: 19020783
[TBL] [Abstract][Full Text] [Related]
37. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
38. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
39. BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.
Pocock CF; Malone M; Booth M; Evans M; Morgan G; Greil J; Cotter FE
Br J Haematol; 1995 Aug; 90(4):855-67. PubMed ID: 7669664
[TBL] [Abstract][Full Text] [Related]
40. Loss of FHIT expression in gastric carcinoma.
Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]